Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells.

Cancer research | Jan 1, 2000

p202, an IFN-inducible protein, interacts with several important regulatory proteins, leading to growth arrest or differentiation. In this report, we demonstrate that, in addition to inhibiting in vitro cell growth, p202 can also suppress the tumorigenicity of breast cancer cells in vivo. Furthermore, we found that p202 expression could sensitize breast cancer cells to apoptosis induced by tumor necrosis factor alpha treatment. One possible mechanism contributing to this sensitization is the inactivation of nuclear factor-kappaB by its interaction with p202. These results provide a scientific basis for a novel therapeutic strategy that combines p202 and tumor necrosis factor alpha treatment against breast cancer.

Pubmed ID: 10646849 RIS Download

Mesh terms: Apoptosis | Breast Neoplasms | Carrier Proteins | Female | Humans | Intracellular Signaling Peptides and Proteins | NF-kappa B | Neoplasm Proteins | Phenotype | Phosphoproteins | Transfection | Tumor Cells, Cultured | Tumor Necrosis Factor-alpha | Tumor Suppressor p53-Binding Protein 1